Evidence map›Paper›PMID 32006538›Full record

ArticleNeurotoxicology2020

Magnitude of behavioral deficits varies with job-related chlorpyrifos exposure levels among Egyptian pesticide workers.

W Kent Anger, Fayssal M Farahat, Pamela J Lein, Michael R Lasarev, James R Olson, Taghreed M Farahat, Diane S Rohlman

Abstract read
In one paragraph

Article in Neurotoxicology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Mechanisms of organophosphate neurotoxicity.Current opinion in toxicology · 2021
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

W Kent AngerOregon Health & Science University, Institute of Occupational Health Sciences, Portland, OR 97239, USA. Electronic address: anger@ohsu.edu.
Fayssal M FarahatMenoufia University, Department of Public Health and Community Medicine, Menoufia, Egypt; King AbdulAziz Medical City, King Saud bin AbdulAziz University for Health Sciences, Jeddah, Saudi Arabia.
Pamela J LeinOregon Health & Science University, Institute of Occupational Health Sciences, Portland, OR 97239, USA; Department of Molecular Biosciences, University of California-Davis, School of Veterinary Medicine, Davis, CA 95616, USA.
Michael R LasarevOregon Health & Science University, Institute of Occupational Health Sciences, Portland, OR 97239, USA.
James R OlsonDepartment of Pharmacology and Toxicology, School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, NY 14214, USA.
Taghreed M FarahatMenoufia University, Department of Public Health and Community Medicine, Menoufia, Egypt.
Diane S RohlmanOregon Health & Science University, Institute of Occupational Health Sciences, Portland, OR 97239, USA; Occupational and Environmental Health, University of Iowa, Iowa City, IA 52242, USA.

Funding

Biomarkers of Organophosphorus Pesticide-Induced NeurotoxicityR01ES016308 · NIEHS · OREGON HEALTH & SCIENCE UNIVERSITY · PI ANGER, WYNDHAM KENT, LEIN, PAMELA J · 2008 to 2011
$2.6M
NIEHS NIH HHS R01 ES016308
6 · The paper itself

Abstract

Chronic occupational exposure to organophosphorus pesticides (OPs) is consistently associated with deficits on behavioral tests when compared to unexposed comparison groups. However, a dose-response relationship has yet to be established, leading some to doubt an association between occupational OP exposure and behavioral deficits. Pesticide application teams in Egypt who are primarily exposed to one OP, chlorpyrifos (CPF), were recruited into a field assessment. Trail Making A and the more challenging Trail Making B tests were administered to 54 engineers (who supervise the pesticide application process, usually from the side of the field), 59 technicians (who guide the pesticide applicators in the field), 31 applicators (who mix and apply pesticides using knapsack sprayers), and 150 controls (who did not work in the fields) at two different times during the OP application season as well as immediately after applications had ended and 1.5 months later. All participants were males since only males work on pesticide application teams in Egypt. Urinary levels of 3,5,6-trichloro-2-pyridinol (TCPy), a specific metabolite of CPF, confirmed the pattern of lower to higher CPF exposures from engineers to technicians to applicators, and these were all greater than urinary metabolite levels in controls. A consistent relationship between job title and performance speed on the behavioral task was observed: Controls had the best (fastest) performance on Trail Making A and B tests throughout the application season, and applicators had significantly slower performance than engineers on Trail Making A (p = 0.015) and B (p = 0.003). However, individual urinary TCPy, blood acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) levels did not predict individual performance. This study identifies a dose-related effect based on job title, which serves as a surrogate for chronic exposure in that differing job titles exhibit varying group exposure levels. The results establish that chronic occupational exposure to chlorpyrifos is neurotoxic and suggest that the classic biomarkers of recent CPF exposure are not predictive of chronic exposure effects.

Indexed as

AcetylcholinesteraseAttentionButyrylcholinesteraseChlorpyrifosEgyptExecutive FunctionHumansMaleNeuropsychological TestsOccupational ExposurePesticidesPyridones3,5,6-trichloro-2-pyridinolAcetylcholinesteraseButyrylcholinesteraseChlorpyrifosPesticidesPyridonesChlorpyrifosDose responseNeurotoxicologyOccupational exposureOPOrganophosphorus pesticide

Identifiers

PMID32006538
PMCPMC7085493

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.